174 related articles for article (PubMed ID: 37443046)
1. Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis.
Calderon B; Vazquez L; Belkacemi M; Pourel N
Eur J Med Res; 2023 Jul; 28(1):233. PubMed ID: 37443046
[TBL] [Abstract][Full Text] [Related]
2. Radionecrosis after repeated courses of radiotherapy under stereotactic conditions for brain metastases: Analysis of clinical and dosimetric data from a retrospective cohort of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Cox DG; Bund C; Antoni D; Cebula H; Noel G
Cancer Radiother; 2022 Sep; 26(5):692-702. PubMed ID: 35715354
[TBL] [Abstract][Full Text] [Related]
3. Radionecrosis after stereotactic radiotherapy for brain metastases.
Le Rhun E; Dhermain F; Vogin G; Reyns N; Metellus P
Expert Rev Neurother; 2016 Aug; 16(8):903-14. PubMed ID: 27177183
[TBL] [Abstract][Full Text] [Related]
4. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
5. Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases.
Lucia F; Key S; Dissaux G; Goasduff G; Lucia AS; Ollivier L; Pradier O; Schick U
Radiother Oncol; 2019 Jan; 130():132-138. PubMed ID: 30017105
[TBL] [Abstract][Full Text] [Related]
6. [Risk of radionecrosis after hypofractionated stereotactic radiotherapy targeting the postoperative resection cavity of brain metastases].
Keller A; Doré M; Antoni D; Menoux I; Thillays F; Clavier JB; Delpon G; Jarnet D; Bourrier C; Lefebvre F; Chibbaro S; Darié I; Proust F; Noël G
Cancer Radiother; 2017 Aug; 21(5):377-388. PubMed ID: 28551018
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
[TBL] [Abstract][Full Text] [Related]
8. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
Donovan EK; Parpia S; Greenspoon JN
Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
[TBL] [Abstract][Full Text] [Related]
9. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
[TBL] [Abstract][Full Text] [Related]
10. Impact of concomitant systemic treatments on toxicity and intracerebral response after stereotactic radiotherapy for brain metastases.
Guénolé M; Lucia F; Bourbonne V; Dissaux G; Reygagne E; Goasduff G; Pradier O; Schick U
BMC Cancer; 2020 Oct; 20(1):991. PubMed ID: 33050910
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the risk factors in the development of radionecrosis in patients with brain metastases undergoing stereotactic radiotherapy.
Doğan B; Demir H; Işık N; Gunalp G; Günbey HP; Yaprak G
Br J Radiol; 2024 May; 97(1157):1022-1028. PubMed ID: 38426391
[TBL] [Abstract][Full Text] [Related]
12. Surgical bed stereotactic radiotherapy of brain metastases: Clinical outcome and predictors of local and distant brain failure.
Mousli A; Bihin B; Gustin T; Koerts G; Mouchamps M; Daisne JF
Cancer Radiother; 2020 Jul; 24(4):298-305. PubMed ID: 32173270
[TBL] [Abstract][Full Text] [Related]
13. Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.
Leeman JE; Clump DA; Flickinger JC; Mintz AH; Burton SA; Heron DE
Neuro Oncol; 2013 Dec; 15(12):1732-8. PubMed ID: 24243914
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.
Minniti G; Clarke E; Lanzetta G; Osti MF; Trasimeni G; Bozzao A; Romano A; Enrici RM
Radiat Oncol; 2011 May; 6():48. PubMed ID: 21575163
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
[TBL] [Abstract][Full Text] [Related]
16. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases.
Kohutek ZA; Yamada Y; Chan TA; Brennan CW; Tabar V; Gutin PH; Yang TJ; Rosenblum MK; Ballangrud Å; Young RJ; Zhang Z; Beal K
J Neurooncol; 2015 Oct; 125(1):149-56. PubMed ID: 26307446
[TBL] [Abstract][Full Text] [Related]
17. SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases.
Crouzen JA; Petoukhova AL; Broekman MLD; Fiocco M; Fisscher UJ; Franssen JH; Gadellaa-van Hooijdonk CGM; Kerkhof M; Kiderlen M; Mast ME; van Rij CM; Nandoe Tewarie R; van de Sande MAE; van der Toorn PPG; Vlasman R; Vos MJ; van der Voort van Zyp NCMG; Wiggenraad RGJ; Wiltink LM; Zindler JD
BMC Cancer; 2023 Mar; 23(1):273. PubMed ID: 36964529
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population.
Holub K; Louvel G
Clin Transl Oncol; 2021 Jul; 23(7):1463-1473. PubMed ID: 33464481
[TBL] [Abstract][Full Text] [Related]
19. Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy.
Uto M; Ogura K; Katagiri T; Takehana K; Mizowaki T
Radiat Oncol; 2021 Jul; 16(1):140. PubMed ID: 34321033
[TBL] [Abstract][Full Text] [Related]
20. Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases.
Ohtakara K; Hayashi S; Nakayama N; Ohe N; Yano H; Iwama T; Hoshi H
J Neurooncol; 2012 May; 108(1):201-9. PubMed ID: 22392126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]